Nochez Yannick, Arsene Sophie, Gueguen Naig, Chevrollier Arnaud, Ferré Marc, Guillet Virginie, Desquiret Valérie, Toutain Annick, Bonneau Dominique, Procaccio Vincent, Amati-Bonneau Patrizia, Pisella Pierre-Jean, Reynier Pascal
Centre Hospitalier Universitaire de Tours, Service d'Ophtalmologie, Tours, France.
Mol Vis. 2009;15:598-608. Epub 2009 Mar 27.
Autosomal dominant optic atrophy (ADOA, OMIM 165500), an inherited optic neuropathy that leads to retinal ganglion cell degeneration and reduced visual acuity during the early decades of life, is mainly associated with mutations in the OPA1 gene. Here we report a novel ADOA phenotype associated with a new pathogenic OPA1 gene mutation.
The patient, a 62-year-old woman, was referred for acute, painless, and severe visual loss in her right eye. Acute visual loss in her left eye occurred a year after initial presentation. MRI confirmed the diagnosis of isolated atrophic bilateral optic neuropathy. We performed DNA sequencing of the entire coding sequence and the exon/intron junctions of the OPA1 gene, and we searched for the mitochondrial DNA mutations responsible for Leber hereditary optic atrophy by sequencing entirely mitochondrial DNA. Mitochondrial respiratory chain complex activity and mitochondrial morphology were investigated in skin fibroblasts from the patient and controls.
We identified a novel heterozygous missense mutation (c.2794C>T) in exon 27 of the OPA1 gene, resulting in an amino acid change (p.R932C) in the protein. This mutation, which affects a highly conserved amino acids, has not been previously reported, and was absent in 400 control chromosomes. Mitochondrial DNA sequence analysis did not reveal any mutation associated with Leber hereditary optic neuropathy or any pathogenic mutations. The investigation of skin fibroblasts from the patient revealed a coupling defect of oxidative phosphorylation and a larger proportion of short mitochondria than in controls.
The presence of an OPA1 mutation indicates that this sporadic, late-onset acute case of optic neuropathy is related to ADOA and to a mitochondrial energetic defect. This suggests that the mutational screening of the OPA1 gene would be justified in atypical cases of optic nerve atrophy with no evident cause.
常染色体显性遗传性视神经萎缩(ADOA,OMIM 165500)是一种遗传性视神经病变,在生命的最初几十年会导致视网膜神经节细胞变性和视力下降,主要与OPA1基因突变有关。在此,我们报告一种与新的致病性OPA1基因突变相关的新型ADOA表型。
该患者为一名62岁女性,因右眼急性、无痛性严重视力丧失前来就诊。初次就诊一年后,其左眼出现急性视力丧失。MRI确诊为孤立性双侧萎缩性视神经病变。我们对OPA1基因的整个编码序列和外显子/内含子连接区进行了DNA测序,并通过对整个线粒体DNA进行测序,寻找导致Leber遗传性视神经萎缩的线粒体DNA突变。对患者和对照者的皮肤成纤维细胞进行了线粒体呼吸链复合体活性和线粒体形态学研究。
我们在OPA1基因的第27外显子中鉴定出一种新的杂合错义突变(c.2794C>T),导致蛋白质中的氨基酸发生变化(p.R932C)。这种影响高度保守氨基酸的突变此前未见报道,在400条对照染色体中也未出现。线粒体DNA序列分析未发现与Leber遗传性视神经病变相关的任何突变或任何致病性突变。对患者皮肤成纤维细胞的研究显示,氧化磷酸化存在偶联缺陷,短线粒体的比例高于对照者。
OPA1突变的存在表明,这种散发性、迟发性急性视神经病变病例与ADOA及线粒体能量缺陷有关。这表明,在无明显病因的非典型视神经萎缩病例中,对OPA1基因进行突变筛查是合理的。